Cargando…
Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia
Case series Patients: Female, 34-year-old • Female, 31-year-old • Female, 29-year-old • Female, 24-year-old Final Diagnosis: SARS-CoV-2 Symptoms: Hypoxia Medication: Intravenous immunoglobulin Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Rare disease BACKGROUND: Despite unpreceden...
Autores principales: | Geriak, Matthew, McGrosso, Dominic, Gonzalez, David J., Dehner, Matthew, Sakoulas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115731/ https://www.ncbi.nlm.nih.gov/pubmed/35567293 http://dx.doi.org/10.12659/AJCR.936734 |
Ejemplares similares
-
71. Use of Intravenous Immunoglobulin Therapy Reduces Progression to Mechanical Ventilation in COVID-19 Patients with Moderate to Severe Hypoxia
por: Sakoulas, George, et al.
Publicado: (2020) -
Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008) -
Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
por: Kwapisz, Dorota, et al.
Publicado: (2023) -
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020) -
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
por: Mohtadi, Negar, et al.
Publicado: (2020)